Supportive and Palliative Care for Patients with Oral Cancer

Referencias bibliográficas

• National Consensus Project for Quality Palliative Care Task Force. The clinical practice guideline for quality palliative care. 3rd ed. Pittsburgh: National Consensus Project for Quality Palliative Care; 2013.
• Diz Dios P, Seoane Lestón J. Oral cancer pain. Oral Oncol. 2010;46(6):448–51.
• Saunders DP, Epstein JB, Elad S, Allemano J, Bossi P, van de Wetering MD, Rao NG, Potting C, Cheng KK, Freidank A, Brennan MT, Bowen J, Dennis K, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3191–207.
• Shah JP, Gil Z. Current concepts in management of oral cancer--surgery. Oral Oncol. 2009;45(4–5):394–401.
• Diz Dios P, Fernández Feijoo J, Castro Ferreiro M, Alvarez Alvarez J. Functional consequences of partial glossectomy. J Oral Maxillofac Surg. 1994;52(1):12–4.
• Siddall KZ, Rogers SN, Butterworth CJ. The prosthodontic pathway of the oral cancer patient. Dent Update. 2012;39(2):98–100, 103–6.
• Sonis ST. Oral mucositis. Anticancer Drugs. 2011;22(7):607–12.
• Jensen SB, Jarvis V, Zadik Y, Barasch A, Ariyawardana A, Hovan A, Yarom N, Lalla RV, Bowen J, Elad S, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(11):3223–32.
• Villa A, Sonis ST. Pharmacotherapy for the management of cancer regimen-related oral mucositis. Expert Opin Pharmacother. 2016;17(13):1801–7.
• Vissink A, van Luijk P, Langendijk JA, Coppes RP. Current ideas to reduce or salvage radiation damage to salivary glands. Oral Dis. 2015;21(1):e1–10.
• Riley P, Glenny AM, Hua F, Worthington HV. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy. Cochrane Database Syst Rev. 2017;7:CD012744.
• Kamstra JI, van Leeuwen M, Roodenburg JLN, Dijkstra PU. Exercise therapy for trismus secondary to head and neck cancer: a systematic review. Head Neck. 2017;39(11):2352–62.
• Owosho AA, Tsai CJ, Lee RS, Freymiller H, Kadempour A, Varthis S, Sax AZ, Rosen EB, Yom SK, Randazzo J, Drill E, Riedel E, Patel S, Lee NY, Huryn JM, Estilo CL. The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): the Memorial Sloan Kettering Cancer Center experience. Oral Oncol. 2017;64:44–51.
• Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H. The use of hyperbaric oxygen for the prevention and management of osteoradionecrosis of the jaw: a Dana-Farber/Brigham and Women’s Cancer Center multidisciplinary guideline. Oncologist. 2017;22(3):343–50.
• De Felice F, de Vincentiis M, Luzzi V, Magliulo G, Tombolini M, Ruoppolo G, Polimeni A. Late radiation-associated dysphagia in head and neck cancer patients: evidence, research and management. Oral Oncol. 2018;77:125–30.
• Valdez JA, Brennan MT. Impact of oral cancer on quality of life. Dent Clin N Am. 2018;62(1):143–54.
• Rogers SN, Ahiaku S, Lowe D. Is routine holistic assessment with a prompt list feasible during consultations after treatment for oral cancer? Br J Oral Maxillofac Surg. 2018;56(1):24–8.
• Sharp L, Redfearn D, Timmons A, Balfe M, Patterson J. Post-traumatic growth in head and neck cancer survivors: is it possible and what are the correlates? Psychooncology. 2018;27:1517.
• Mitsudo K, Koizumi T, Iida M, Iwai T, Nakashima H, Oguri S, Kioi M, Hirota M, Koike I, Hata M, Tohnai I. Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases. Radiother Oncol. 2014;111(2):306–10.